• en
    • he
    • ru
Home » Insights » Transactions » Alcobra Ltd.

Alcobra Ltd.

12.09.2017 | NASDAQ

The International team counseled Alcobra Pharma Ltd in a Reverse IPO with Arcturus Therapeutics Inc. (“Arcturus”) .

Advocates Shy Baranov, Itamar Mei-Zahav and Boaz Shiffman of our Tel Aviv office, and Partners Mitchell C. Stein, Howard Berkenblit and Douglas Stransky from our US offices, advised and represented the Alcobra Pharma Ltd.  (which is currently a registered company in Israel and traded on Nasdaq) in its reverse IPO merger with Arcturus Therapeutics Inc. (“Arcturus”) at a transaction valued at $117,000,000.

Alcobra Pharma Ltd. is an emerging pharmaceutical company focused on the development of new medications to treat CNS and cognitive disorders.

Recent Activity

All Media
This Media article belongs to the category: Transactions The article was published in the 24th December 2019.

Article title: On Track Innovations
This Media article belongs to the category: News The article was published in the 17th December 2019. | Jerusalem Post

Article title: Expert: Timing Key for US Expansion
This Media article belongs to the category: Events The article was published in the 08th September 2019. | New York City

Article title: Israeli-American Council (IAC) EDGE Summit
This Media article belongs to the category: Publications The article was published in the 15th May 2019. | The Jerusalem Post

Article title: Israeli Startups, IPO’s and Beyond
This Media article belongs to the category: News The article was published in the 16th April 2019. | ZAG-S&W

Article title: IVC Research Center and ZAG Report: Israeli High-Tech Companies Raised $1.55 Billion in 128 Deals in Q1/2019
This Media article belongs to the category: Publications The article was published in the 28th February 2019. | Zurich

Article title: Israeli Life Sciences Cluster: Promises for Global Stakeholders
This Media article belongs to the category: Transactions The article was published in the 12th February 2019. | Public Offering

Article title: Oppenheimer
This Media article belongs to the category: News The article was published in the 09th January 2019. | IVC Research Center

Article title: IVC | ZAG High-Tech Capital Raising Report: 2018 Marks All-Time Record as Israeli High-Tech Companies Raise $6.4 Billion in 623 Deals
This Media article belongs to the category: Transactions The article was published in the 14th May 2018. | TASE

Article title: IceCure Ltd.
This Media article belongs to the category: News The article was published in the 24th October 2017. | Globes

Article title: The quarterly research report of ZAG and IVC-Research Center was published
This Media article belongs to the category: Transactions The article was published in the 18th October 2017. | NASDAQ

Article title: Radcom Ltd.
This Media article belongs to the category: Transactions The article was published in the 15th June 2017. | NASDAQ

Article title: Foresight Autonomous Holdings Ltd.
This Media article belongs to the category: Transactions The article was published in the 15th May 2017. | Fundraising

Article title: BiomX Ltd.
This Media article belongs to the category: Events The article was published in the 12th March 2017. | Dana Point, California

Article title: ZAG is proud to be a Silver Sponsor of the 29th Annual ROTH Conference
This Media article belongs to the category: Transactions The article was published in the 03rd March 2017. | IPO

Article title: Therapix Biosciences